Logo

OUR PIPELINE

With our partners in Biotech and Pharma we have built a track record of 32+ successful drug discovery and development partnerships at multiple stages of maturity, clinical development and market readiness. Together with our partners we drive therapeutics programs through all relevant inflection points independent of disease  area and therapeutic modality.
Therapeutic AreaIndicationTargetStagePartner
OncologySolid tumorsAKAP-4Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchVerik bio
OncologyPancreatic cancerPI3KPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchLand of Hessen
OncologyMultiple oncology indicationsMetAP2Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchCureteq
OncologyMultiple oncology indicationsOX40Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchCureteq
OncologyPancreatic cancerConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
Oncology and Inflammatory diseasesConfidentialPIM familyPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchInflection Biosciences
ImmunologyMultiple immunology indicationsIL-17Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchCureteq
Inflammatory disordersConfidentialConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchChain Pharmaceuticals
Inflammatory disordersConfidentialConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchChain Pharmaceuticals
Inflammatory disordersConfidentialConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchChain Pharmaceuticals
Neurodegenerative diseasesAlzhiemers diseaseConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchDiscoveric bio alpha
Mental health disordersDepressionConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
Mental health disordersAnxietyConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
Mental health disordersSleep disorderConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
Mental health disordersADHDConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
Mental health disordersOpoid abuseConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
Mental health disordersSchizophreniaConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
Sensori-neural diseasesConfidentialConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
Metabolic diseasesT1D and co-morbiditiesConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
CardiologyConfidentialConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
Dermatology + othersConfidentialTLRPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
DermatologyConfidentialTLRPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchChain Pharmaceuticals
DermatologyConfidentialTLRPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchChain Pharmaceuticals
Infectious diseasesAntimicrobial resistanceConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchDiscoveric bio beta
Infectious diseasesCovid-193CLProPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchLand of Hessen
Pain related indicationsConfidentialConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchChain Pharmaceuticals
ICU treatmentConfidentialConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchChain Pharmaceuticals
Rare diseasesConfidentialConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
Rare diseasesConfidentialConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
Multiple TAsConfidentialConfidentialPre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-LaunchConfidential
Partner with us
speaker-icon
What’s New in Ontosight® Terminal 1 . 1

What’s New in Ontosight® Terminal 1 . 1

Read more
Partex Accelerates Antibody Engineering for Neurodegenerative Diseases Using NVIDIA-Accelerated AI / ML Platform

Partex Accelerates Antibody Engineering for Neurodegenerative Diseases Using NVIDIA-Accelerated AI / ML Platform

Read more
Partex and Ark Biopharmaceutical Expand Strategic Collaboration with New Out-Licensing Agreement for ATR Inhibitor AK0658

Partex and Ark Biopharmaceutical Expand Strategic Collaboration with New Out-Licensing Agreement for ATR Inhibitor AK0658

Read more
award

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More
ontosight ad illustration

Ontosight®

FREE for a limited time

Try now

We use first-party cookies to provide you the best possible experience. Necessary By clicking "Accept", you agree to the use of our cookies on your device.